Similar to as in the blood, the frequency and number of tumor-infiltrating antigen-specific CD8+ T cells were further increased when the sum of Adpgk-, Reps1- and Rpl18-specific CD8+ T cells was considered. This evidence concerns the gene CD8A and neoplasm.